The generic name of Kodan is Entacapone Tablets, which is indicated for Parkinson’s patients in the middle to late stages of the disease, and is particularly suitable for Parkinson’s patients who develop complications of motor fluctuations.
Parkinson’s disease is a degenerative disease of the central nervous system commonly seen in middle-aged and elderly people, which is mainly characterized by involuntary shaking of the limbs at rest, muscle tonus, bradykinesia, delayed movement and poor postural balance. Entacapone is effective in Parkinson’s disease.
Entacapone is a reversible specific catechol-O-methyltransferase (COMT) inhibitor that acts primarily in the periphery. It is widely used clinically for Parkinson’s disease and motor fluctuation symptoms. Entacapone inhibits levodopa metabolism and improves its bioavailability.
Its common adverse effects include diarrhea, exacerbation of Parkinson’s disease symptoms, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, confusion, nightmares, falls, and vertigo. It is prohibited for those who are allergic to this product.
Parkinson’s patients must seek timely medical treatment, under the guidance of a professional doctor, and use the drug in strict compliance with medical advice.